|
Match
|
Document |
Document Title |
|
|
7618649 |
Extended release oral dosage composition
A bilayer solid composition comprising (a) an immediate release first layer comprising an anti-allergic effective amount of desloratadine and at least one pharmaceutically acceptable excipient and...
|
|
|
7585520 |
Compositions containing both sedative and non-sedative antihistamines and sleep aids
Compositions containing both a sedative compound and a non-sedative antihistamine are provided. More particularly, compositions for administration at bedtime containing a sedating antihistamine or...
|
|
|
7553500 |
Pharmaceutical composition having uniform drug distribution and potency
Pharmaceutical compositions having uniform drug distribution and potency utilizing laxofoxifene as an active ingredient and containing a silicon dioxide to reduce loss of the active ingredient...
|
|
|
7537784 |
Modified release tablet of bupropion hydrochloride
A modified-release tablet of bupropion hydrochloride comprising (i) a core comprising an effective amount of bupropion hydrochloride, a binder, a lubricant; and (ii) a control releasing coat...
|
|
|
7514100 |
Controlled release hydrocodone formulations
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
|
|
|
7488498 |
Antidiabetic preparation for oral administration
There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a...
|
|
|
7482022 |
Palatable chewable tablet
A palatable chewable tablet is described herein for oral administration of cetirizine dihydrochloride. The formulation is made more palatable by incorporating a combination of a grape flavoring...
|
|
|
7470435 |
Extended release venlafaxine formulation
A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
|
|
|
7438927 |
Methods of treatment using a gastric retained gabapentin dosage
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
|
|
|
7435427 |
Pharmaceutical semi-solid composition of isotretinoin
An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an...
|
|
|
7419684 |
System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
A system and method for manufacturing oral osmotic drug delivery devices including the use of a mathematical model in deriving relationships between parameters used in manufacturing the devices for...
|
|
|
7413751 |
Methods of treatment using a gastric retained losartan dosage
A method of treatment for hypertension and other disease states is described, which comprises the delivery of losartan in a gastric retained dosage form.
|
|
|
7387792 |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
New pharmaceutical compositions in unit dosage form are disclosed for both intraoral and oral administration to a patient, said unit dosage form configured to be placed intraorally of said patient,...
|
|
|
7384653 |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
The present invention provides an oral dosage form comprising a first composition and a second composition. The first composition comprises an effective amount of a therapeutic agent and the second...
|
|
|
7332183 |
Multilayer dosage forms containing NSAIDs and triptans
The present invention is directed to multilayer pharmaceutical tablets in which an NSAID and a triptan are present in separate and distinct layers. The layers are in a side-by-side configuration,...
|
|
|
7329418 |
Pharmaceutical tablets having height greater than width
An immediate release compressed pharmaceutical tablet that has two or more segments and a top and a bottom and has a height that exceeds the width of the tablet. The height is measured vertically...
|
|
|
7318935 |
Pharmaceutical tablets with active and inactive segments
An immediate release compressed pharmaceutical tablet that has two or more segments and a top and a bottom and has a height that exceeds the width of the tablet. The height is measured vertically...
|
|
|
7314641 |
High-bioavailability particle coated with fungicide and polymer
The present invention discloses a high-bioavailability particle coated with fungicide and polymer, which mainly comprises: (a) a coating layer including fungicide, a polymer, an acidic substance,...
|
|
|
7314638 |
Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof
The present invention relates to a simple and effective method for preparing a tamsulosin HCl sustained-release tablet and a tamsulosin HCl sustained-release tablet produced thereby. The method...
|
|
|
7300668 |
System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
The present invention includes controlled release dosage forms and methods of designing and manufacturing dosage forms to obtain specific release profiles, for example, zero-order release profiles,...
|
|
|
7294347 |
Coating compositions for bitterness inhibition
The present invention discloses coating compositions with taste masking property, comprising a blend of pH sensitive polymers and optionally a pH independent polymer or a blend of the pH sensitive...
|
|
|
7276253 |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
The invention relates to a stable medicament for oral administration which comprises
(a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole,...
|
|
|
7276252 |
Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
A drug delivery device such as an oral dosage form (ODF) with a toxic or potent core encapsulated by a non-toxic region. The non-toxic region may be a region including multiple layers, coatings,...
|
|
|
7250176 |
Method of treating a bacterial infection
Bacterial infections may be treated using a high dosage regimen of amoxicillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
|
|
|
7235258 |
Sustained-release formulations for treating CNS-mediated disorders
Sustained-release compositions for delivering therapeutic concentrations of isovaleramide, isovaleric acid, and certain structurally related compounds are provided for the treatment for a variety...
|
|
|
7229640 |
Paroxetine controlled release compositions
A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
|
|
|
7226614 |
Tablet comprising cetirizine and pseudoephedrine
The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of...
|
|
|
7220430 |
Sustained-release preparation and process for producing the same
The present invention is to provide a sustained release preparation comprising a drug-containing core substance and a multilayered coating layer covering the core substance, wherein all adjacent...
|
|
|
7217430 |
Compositions and methods of treatment comprising amoxicillin and potassium clavulanate with xanthan
Bacterial infections may be treated using a high dosage regimen of amoxicillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
|
|
|
7217429 |
Tableted oral pharmaceutical dosage form, with enteric coating, containing a compound of benzimidazole labile in an acid medium
The pharmaceutical dosage form consists of a plurality of units containing a benzimidazole compound labile in an acid medium as the active principle, each unit being comprised of an inert core, a...
|
|
|
7160559 |
Controlled release galantamine composition
The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions.
|
|
|
7157100 |
Pharmaceutical composition for controlled drug delivery system
The present invention describes a novel controlled release multilayer composition that is capable of delivering a first active agent from one layer immediately followed by continuous controlled...
|
|
|
7157095 |
Multiple-delayed release antifungal product, use and formulation thereof
An anti-fungal product is comprised of at least three delayed release dosages forms, each of which has a different release profile, with the C max for the anti-fungal product being reached in less...
|
|
|
7147870 |
Osmotic device containing pseudoephedrine and an H1 antagonist
The present invention provides an osmotic device containing controlled release pseudoephedrine in the core in combination with a rapid release H1 antagonist in an external coat. A wide range of H1...
|
|
|
7125567 |
Process for producing an oral sustained-release preparation of fasudil hydrochloride
Disclosed is an oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof, the preparation...
|
|
|
7125563 |
Sustained release pharmaceutical preparations and methods for producing the same
An extended release tablet comprising a core including albuterol sulfate and extended release agent; and an extended release coating on the core to provide for sustained release of the albuterol...
|
|
|
7105180 |
Stable galenic preparations comprising a benzimidazole and method for the production thereof
The invention relates to a novel benzimidazole formulation and to a process for its production. The benzimidazole formulation comprises a layer comprising the benzimidazole compound together with...
|
|
|
7097851 |
Oral formulation for gastrointestinal drug delivery
An oral formulation for gastrointestinal drug delivery which comprises an adhesion site-controlling layer for attaching the formulation to the selected site in the digestive tract, a drug-carrying...
|
|
|
7094427 |
Combination immediate release controlled release levodopa/carbidopa dosage forms
The present invention relates to dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated...
|
|
|
7090861 |
Sustained release delivery systems for solutes
The present invention relates to devices that allow for linear, sustained-release of solutes with adjustable initial-release kinetics. In particular, the present invention relates to devices for...
|
|
|
7083807 |
Pharmaceutical compositions for the controlled release of active substances
The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising
a) the said at least one active...
|
|
|
7060295 |
Formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
The compositions and dosage forms of the invention are clinically useful as methods for increasing the effectiveness, efficiency and safety of biguanides (metformin) and/or sulfonylureas in the...
|
|
|
7041244 |
Method for producing moulded bodies
A process for producing tablets comprising one or more active substances, in which pulverulent to granular starting components are shaped and then solidified, wherein the solidification takes place...
|
|
|
7030162 |
Treatment of migraine headache
The invention is directed to pharmaceutical compositions useful in the treatment of migraine. The compositions contain metoclopramide and one or more NSAIDs in unit dosage form. By selecting NSAIDs...
|
|
|
RE39069 |
Multi-layered osmotic device
The present invention provides a simple and improved multi-layered osmotic device ( 1 ) that is capable of delivering a first active agent in an outer lamina ( 2 ) to one environment of use and a...
|
|
|
7022342 |
Controlled release oral dosage form of beta-adrenergic blocking agents
A sustained release beta-adrenergic receptor blocking agent, preferably propranolol, formulation.
|
|
|
7022341 |
Pharmaceutical compositions containing epinastine and pseudoephedrine
The present invention relates to novel oral pharmaceutical compositions comprising as pharmaceutically active compounds a combination of an antihistaminic-effective amount of epinastine or a...
|
|
|
7014867 |
Tablet comprising cetirizine and pseudoephedrine
The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of...
|
|
|
7011849 |
Second release phase formulation
Formulations are provided herein which allow for a once daily dosing regimen for amoxicillin and clavulanic acid.
|
|
|
7008641 |
Osmotic device containing venlafaxine and an anti-psychotic agent
The present invention provides an osmotic device containing controlled release venlafaxine in the core in combination with an anti-psychotic agent in a rapid release external coat. A wide range of...
|